Phase 2 biotech developing T cell immunotherapies for cancer/infectious diseases.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/22/2019 |
Offer Price | $14.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $84 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/17/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $84 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2011 |
Employees at IPO | 78 |
Website www.hookipapharma.com |